These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


421 related items for PubMed ID: 15689195

  • 1. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department.
    Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C.
    Cephalalgia; 2005 Mar; 25(3):199-204. PubMed ID: 15689195
    [Abstract] [Full Text] [Related]

  • 2. Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache.
    Corbo J, Esses D, Bijur PE, Iannaccone R, Gallagher EJ.
    Ann Emerg Med; 2001 Dec; 38(6):621-7. PubMed ID: 11719739
    [Abstract] [Full Text] [Related]

  • 3. Single-dose intravenous tramadol for acute migraine pain in adults: a single-blind, prospective, randomized, placebo-controlled clinical trial.
    Alemdar M, Pekdemir M, Selekler HM.
    Clin Ther; 2007 Jul; 29(7):1441-7. PubMed ID: 17825695
    [Abstract] [Full Text] [Related]

  • 4. Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study.
    Honkaniemi J, Liimatainen S, Rainesalo S, Sulavuori S.
    Headache; 2006 May; 46(5):781-7. PubMed ID: 16643581
    [Abstract] [Full Text] [Related]

  • 5. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ, Cady R, Dodick D, Freitag FG, Hutchinson SL, Twomey C, Kuhn TA.
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [Abstract] [Full Text] [Related]

  • 6. Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial.
    Tanen DA, Miller S, French T, Riffenburgh RH.
    Ann Emerg Med; 2003 Jun; 41(6):847-53. PubMed ID: 12764341
    [Abstract] [Full Text] [Related]

  • 7. A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine.
    Friedman BW, Esses D, Solorzano C, Dua N, Greenwald P, Radulescu R, Chang E, Hochberg M, Campbell C, Aghera A, Valentin T, Paternoster J, Bijur P, Lipton RB, Gallagher EJ.
    Ann Emerg Med; 2008 Oct; 52(4):399-406. PubMed ID: 18006188
    [Abstract] [Full Text] [Related]

  • 8. Metoclopramide versus hydromorphone for the emergency department treatment of migraine headache.
    Griffith JD, Mycyk MB, Kyriacou DN.
    J Pain; 2008 Jan; 9(1):88-94. PubMed ID: 17981511
    [Abstract] [Full Text] [Related]

  • 9. Randomized trial of IV dexamethasone for acute migraine in the emergency department.
    Friedman BW, Greenwald P, Bania TC, Esses D, Hochberg M, Solorzano C, Corbo J, Chu J, Chew E, Cheung P, Fearon S, Paternoster J, Baccellieri A, Clark S, Bijur PE, Lipton RB, Gallagher EJ.
    Neurology; 2007 Nov 27; 69(22):2038-44. PubMed ID: 17942818
    [Abstract] [Full Text] [Related]

  • 10. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial.
    Donaldson D, Sundermann R, Jackson R, Bastani A.
    Am J Emerg Med; 2008 Feb 27; 26(2):124-30. PubMed ID: 18272089
    [Abstract] [Full Text] [Related]

  • 11. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines.
    Friedman BW, Corbo J, Lipton RB, Bijur PE, Esses D, Solorzano C, Gallagher EJ.
    Neurology; 2005 Feb 08; 64(3):463-8. PubMed ID: 15699376
    [Abstract] [Full Text] [Related]

  • 12. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD, Dahlöf CG, Brandes JL, Agosti R, Jones MW, Barrett PS.
    Clin Ther; 2005 Apr 08; 27(4):407-17. PubMed ID: 15922814
    [Abstract] [Full Text] [Related]

  • 13. Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
    Miner JR, Smith SW, Moore J, Biros M.
    Am J Emerg Med; 2007 Jan 08; 25(1):60-4. PubMed ID: 17157685
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 08; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 15. The use of intravenous magnesium sulphate for acute migraine: meta-analysis of randomized controlled trials.
    Choi H, Parmar N.
    Eur J Emerg Med; 2014 Feb 08; 21(1):2-9. PubMed ID: 23921817
    [Abstract] [Full Text] [Related]

  • 16. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT, Finlayson G, Smith TR, Cady RK, Adelman J, Mao L, Wright P, Greenberg SJ, AEGIS Investigator Study Group.
    Headache; 2007 Feb 08; 47(2):189-98. PubMed ID: 17300358
    [Abstract] [Full Text] [Related]

  • 17. Patient-controlled analgesia with lornoxicam vs. dipyrone for acute postoperative pain relief after septorhinoplasty: a prospective, randomized, double-blind, placebo-controlled study.
    Sener M, Yilmazer C, Yilmaz I, Caliskan E, Donmez A, Arslan G.
    Eur J Anaesthesiol; 2008 Mar 08; 25(3):177-82. PubMed ID: 17953792
    [Abstract] [Full Text] [Related]

  • 18. A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department.
    Kostic MA, Gutierrez FJ, Rieg TS, Moore TS, Gendron RT.
    Ann Emerg Med; 2010 Jul 08; 56(1):1-6. PubMed ID: 20045576
    [Abstract] [Full Text] [Related]

  • 19. Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache.
    Jones J, Pack S, Chun E.
    Am J Emerg Med; 1996 May 08; 14(3):262-4. PubMed ID: 8639197
    [Abstract] [Full Text] [Related]

  • 20. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG, Finlayson G, Rapoport AM, Elkind AH, Diamond ML, Unger JR, Fisher AC, Armstrong RB, Hulihan JF, Greenberg SJ, AIMS Investigators.
    Headache; 2007 Apr 08; 47(4):519-30. PubMed ID: 17445101
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.